Tag: Vemurafenib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Vemurafenib

BRAF Kinase Inhibitors Market Analysis, Latest Trends, Growth 2021 | Array BioPharma Inc., Bayer ...

Added to Collection on: 2021-07-22 18:11:11

Tags for this article:

Clinical medicine
Medicine
Cancer
Chemotherapy
Sulfonamides
Orphan drugs
Tyrosine kinase inhibitors
BRAF
Oncogenes
Vemurafenib
Dabrafenib
Novartis
South Africa
Turkey

Click the tags to see associated articles and topics

View Article Details
Plexxikon Wins Patent Infringement Case Against Novartis

Added to Collection on: 2021-07-22 23:37:30

Tags for this article:

Health sciences
Health care
Companies
Daiichi Sankyo
Chemotherapy
Sulfonamides
Plexxikon
Vemurafenib
Dabrafenib
Novartis
BRAF
Pharmaceutical industry in China

Click the tags to see associated articles and topics

View Article Details
Judge Orders Novartis to Cough Up $178 Million to Plexxikon Over Patent Infringements

Added to Collection on: 2021-07-23 15:52:04

Tags for this article:

Companies
Life Sciences
Industry economics)
Daiichi Sankyo
Novartis
Genentech
Plexxikon
Vemurafenib
Roche
Chiron Corporation
GlaxoSmithKline

Click the tags to see associated articles and topics

View Article Details
Market Assessment of BRAF Kinase Inhibitors Industry: Growth Drivers by Top Players like Array ...

Added to Collection on: 2021-07-30 13:18:45

Tags for this article:

Clinical medicine
Medicine
Cancer
Chemotherapy
Sulfonamides
Orphan drugs
Tyrosine kinase inhibitors
Chloroarenes
Protein kinase inhibitor
Vemurafenib
BRAF
Novartis
HOFFMANN-LA ROCHE Ltd
Novartis AG
F. Hoffmann-La Roche Ltd.

Click the tags to see associated articles and topics

View Article Details
Scientists develop new approach to combat treatment-resistant melanoma - News Medical

Added to Collection on: 2021-10-30 10:17:05

Tags for this article:

Medicine
Cancer
Clinical medicine
Melanoma
Temozolomide
Skin cancer
BRAF
Uveal melanoma
Vemurafenib

Click the tags to see associated articles and topics

View Article Details
Kinnate Biopharma Inc. Provides Corporate Update and Highlights Key Upcoming 2022 ...

Added to Collection on: 2022-01-06 21:39:52

Tags for this article:

Medicine
Clinical medicine
Health
Orphan drugs
Cancer treatments
Benzamides
Binimetinib
Organobromides
Melanoma
Targeted therapy
BRAF
Vemurafenib
Kinnate Biopharma Inc.
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
BRAF Kinase Inhibitors Market Outlook 2022 Analysis By Leading Keyplayers - FortBendNow

Added to Collection on: 2022-03-29 10:42:31

Tags for this article:

Clinical medicine
Medicine
Cancer
Chemotherapy
Sulfonamides
Business process
Tyrosine kinase inhibitors
Cancer treatments
BRAF
Vemurafenib
Dabrafenib
Novartis
United States

Click the tags to see associated articles and topics

View Article Details
BRAF Kinase Inhibitors Market Size 2022 – Growth, Opportunities and Worldwide Forecast ...

Added to Collection on: 2022-05-07 14:05:55

Tags for this article:

Organic compounds
Chemical compounds
Chemistry
Orphan drugs
Chemotherapy
Sulfonamides
Chloroarenes
BRAF
Oncogenes
Protein kinase inhibitor
Vemurafenib
Dabrafenib

Click the tags to see associated articles and topics

View Article Details
Encorafenib Plus Binimetinib Improves Long-Term PFS, OS in BRAF V600-Mutant Melanoma

Added to Collection on: 2022-08-01 20:44:47

Tags for this article:

Medicine
Clinical medicine
Orphan drugs
Cancer
Cancer treatments
Encorafenib
Vemurafenib
Binimetinib
Melanoma
BRAF
Progression-free survival
MEK inhibitor
Columbus

Click the tags to see associated articles and topics

View Article Details
Brain Cancer Cells Imitate Neurons, Evading Treatment Strategies - Neuroscience News

Added to Collection on: 2024-01-12 02:59:51

Tags for this article:

Cancer
Oncology
Tyrosine kinase receptors
BRAF
Oncogenes
Glioblastoma
Brain tumor
Temozolomide
Melanoma
Kinase
Hepatocyte growth factor receptor
Vemurafenib

Click the tags to see associated articles and topics

View Article Details